Home›People›Tim Lohoff
Tim Lohoff

Tim Lohoff

Principal, Forbion and director at Slate Medicines.

Director
Updated Nov 11, 2026·Latest SEC filing Mar 11, 2026·Suggest an edit

About Tim Lohoff

Tim Lohoff is a principal, forbion and director at Slate Medicines.

Experience

This experience comes from Tim Lohoff's profile and from SEC filings. For roles taken from filings, the years are when the filings name Tim Lohoff in the role, so the role may have started earlier or lasted longer.

Slate Medicines, Inc. Current
Principal, Forbion and director
2026 – Present · Boston, MA
Develops medicines to prevent migraines and other headache disorders.
Protego Bio Current
Board Member
2025 – Present
Braveheart Bio Current
Board Member
2025 – Present
AIRNA Current
Board Observer
2024 – Present
Seamless Therapeutics Current
Board Observer
2023 – Present
Forbion Current
Principal
2022 – Present
Kynexis Current
Board Observer
2022 – Present
AAVantgarde Bio
Board Observer
2023 – 2026
L.E.K. Consulting
Life Sciences Specialist
2021 – 2022
University of Cambridge
PHD Student
2016 – 2021
Caltech
Visiting PhD Student
2019
Global Biotech Revolution
Vice-President of GapSummit2018
2017 – 2018
Max Planck Institute of Molecular Cell Biology and Genetics (MPI - CBG)
Trainee in the group of Prof. Dr. Tony Hyman (Organization of cytoplasm)
2015 – 2016
Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden
Trainee in the group of Prof. Dr. Frank Buchholz (Medical Systems Biology)
2015
Center for Regenerative Therapies Dresden (CRTD)
Trainee in the group of Prof. Dr. Elly Tanaka (Animal Models of Regeneration)
2014 – 2015
National University of Singapore
Trainee at the Department of Pharmacology in the lab of Prof. Dr. Deron Herr
2014
University of Tennessee
Trainee at the Department of Biochemistry and Cellular and Molecular Biology (BCMB)
2013 – 2014

Key Colleagues at Startups

The people Tim Lohoff works with at each company, as listed on that company's latest Form D.

Slate Medicines, Inc. · Form D, Mar 11, 2026
SP
Sara Pacheco
Executive officer
CX
Cindy Xiong
Director
Neil Buckley
Neil Buckley
President and Chief Operating Officer, director
Gregory Oakes
Gregory Oakes
Chief Executive Officer and Board Director
AL
Andrew Levin
Director

Sources

  1. SECSlate Medicines, Inc. Form D, filed Mar 11, 2026